Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders

Preventive Medicine

Volumn 40, Issue 3, 2005, Pages 274-277

  Minas, M ^a   Dimitropoulos, K ^a   Pastaka, Ch ^a   Papadopoulos, D ^a   Markoulis, N ^a   Gourgoulianis, K I ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Asthma; COPD; GOLD

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE; HUMAN; LUNG DISEASE; MALE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPIROMETRY; VITAL CAPACITY;

AGED; ASTHMA; FEMALE; GREECE; GUIDELINE ADHERENCE; HUMANS; INTERNATIONALITY; MALE; PRACTICE GUIDELINES; PULMONARY DISEASE (SPECIALTY); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WORLD HEALTH;

EID: 7944237258     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2004.06.010     Document Type: Article

References (15)

1. British Thoracic Society BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax. 52(Suppl. 5):1997;S1-S28
2. National Institutes of Health. Global initiative for chronic obstructive lung disease. NHLBI/WHO Workshop Report, April 2001 (Updated 2003).
3. Mahler D.A., Donohue J.F., Barbee R.A., Goldman M.D., Gross N.J., Wisniewski M.E., et al. Efficacy of salmeterol xinofate in the treatment of COPD. Chest. 115:1999;957-965
4. Carverley P.M. Inhaled corticosteroid are beneficial in chronic obstructive pulmonary disease. Am. J. Respir. Care Med. 161:2000;342-344
5. Van den Boom G., Rutten-van Molken M.P., Folgering H., van Weel C., van Schayck C.P. The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program. Prev. Med. 30:2000;302-308
6. National Institutes of Health. Global initiative for chronic obstructive lung disease. NHLBI/WHO Workshop report, April 2002.
7. Schoonjans F., Zalata A., Depuydt C.E., Comhaire F.H. Medcalc: a new computer program for medical statistics. Comput. Methods Programs Biomed. 48:1995;257-262
8. Gourgoulianis K.I., Hamos B., Christou K., Rizopoulou D., Efthimiou A. Prescription of medications by primary care physicians in the light of asthma guidelines. Respiration. 65:1998;18-20
9. Melissinos C., Gourgoulianis K.I., Adamides S. Asthma mortality and medicine consumption. Chest. 107:1995;1771-1772
10. MacIvor R.A., Tshkin D.P. Underdiagnosis of chronic obstructive pulmonary disease: a rationale for spirometry as a screening tool. Can. Respir. J. 8:2001;153-158
11. Nobert F., Voelkel N.F. Raising awareness of COPD in primary care. Chest. 117:2000;372S-375S
12. Takashaki T., Ichinose M., Inoue H., Shirato K., Takishima T. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology. 8:2003;504-508
13. Condemi J.J. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open label trial. Clin. Ther. 23:2001;1529-1541
14. Paggiaro P.L., Dahle R., Bakran I., Frith L., Hollingworth K., Efthimiou J. Multicentre randomized placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet. 351:1998;773-780
15. Gourgoulianis K.I., Hristou K., Molyvdas P.A. Detection of COPD in high-risk populations. Chest. 121:2002;1721